Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT03406520 Completed - Clinical trials for Peritoneal Dialysis Catheter Exit Site Infection

Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients

Start date: March 7, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of chlorhexidine-impregnated disk in preventing catheter exit-site infection in peritoneal dialysis patients

NCT ID: NCT03405064 Completed - Clinical trials for Acute Bacterial Skin and Skin Structure Infections

Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Start date: August 25, 2017
Phase: Phase 3
Study type: Interventional

This is a phase III, multi-center, randomized, active-comparator, study in subjects with ABSSSI. The study has two subgroups for assessment of efficacy and safety - oral subgroup 1 and IV subgroup 2. Each subgroup will comprise of two treatment arms.

NCT ID: NCT03403608 Completed - Joint Infection Clinical Trials

Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections

Start date: March 1, 2017
Phase: N/A
Study type: Observational

For patients having a bone or joint infections, with or without device, optimal surgical therapy could be sometimes non-feasible, especially in the elderly population. Therefore, a medical therapy with oral prolonged suppressive antibiotic therapy (PSAT) seems to be an option to prevent recurrence and prosthesis loosening. Subcutaneous (SC) administration of injectable intravenous antibiotics as prolonged suppressive antibiotic therapy could be a convenient way when oral treatment is not available to facilitate ambulatory care, this practice being considered as routine care. The aim of this study is to evaluate tolerance and efficacy of subcutaneous administration of antibiotics for prolonged suppressive antibiotic therapy in patients having this treatment as part of their routine care.

NCT ID: NCT03400293 Completed - HIV Infections Clinical Trials

Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection

RISE
Start date: January 18, 2018
Phase:
Study type: Observational

This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various important subpopulations such as subjects who are virally suppressed; who we anticipate will be the majority of study subjects. The study design is an observational, cross sectional study employing subjects' own mobile phone devices for data entry.

NCT ID: NCT03399903 Completed - HIV-1-infection Clinical Trials

Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection

Start date: May 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

An open label study will be performed on 80 people with HIV infection who are maintained on effective treatment with antiretroviral drugs.

NCT ID: NCT03397914 Completed - Pediatric Cancer Clinical Trials

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

Start date: January 2017
Phase: Phase 4
Study type: Interventional

Prospective randomized study comparing different colistin dosing regimens in paediatric cancer patient with MDR gram-negative infection or sepsis

NCT ID: NCT03392584 Completed - Infection Clinical Trials

Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters

Start date: October 1, 2016
Phase:
Study type: Observational

The intention of the study is to explore metabolic and inflammatory parameters in the pelvis after abdominoperineal resection for locally advanced rectal cancer in patients that have received radiation therapy before surgery.

NCT ID: NCT03392207 Completed - Clinical trials for Respiratory Tract Infections

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

FLU-06-IB
Start date: April 23, 2018
Phase:
Study type: Observational

Rationale and Background: Since 2013, Butantan Institute has been performing passive pharmacovigilance activities related to its triavalent, fragmented and inactivated vaccine (IB TIV). Objetive: To conduct an active surveillance study focusing on the elderly and health care professionals as part of Butantan pharmacovigilance plan, while passive surveillance activities will continue. The pharmacovigilance plan, via active surveillance, is being implemented in response to WHO requirements for pre-qualification of IB TIV.

NCT ID: NCT03390374 Completed - Clinical trials for Fungal Infections Systemic

Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants

Start date: October 2010
Phase: Phase 4
Study type: Interventional

This study determines the effectiveness of oral nystatin as prophylaxis in order to prevent systemic fungal infection in very low birth weight preterm neonates. 47 participants received oral nystatin and 48 participants received sterile water as part of oral hygiene.

NCT ID: NCT03389360 Completed - Clinical trials for Liver Transplant Infection

Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant

Start date: March 15, 2018
Phase:
Study type: Observational

, the study aimed at assessing the frequency of rising procalcitonin associated with infectious complications in immunosuppressed LDLTRx.